PHI News Room
All News and Press Releases
Enter any phrase or word you would like to search for and click .
PostNews: Press Release
Notice of Annual General Meeting in Phase Holographic Imaging PHI AB (publ)
The shareholders of Phase Holographic Imaging PHI AB (publ), reg. nr. 556542-7811, are hereby invited to attend the annual general meeting on the 31 October 2024 at 11.00 at the company´s office at Skiffervägen 48 in Lund.
PostNews: Press Release
The last day of trading in warrants of series TO 4 is on 1 October 2024
The 1st of October 2024 is the last day of trading in warrants of series TO 4, which were issued in connection with Phase Holographic Imaging PHI AB’s preferential rights issue of units that was carried out in 2022. The exercise period runs until 3 October 2024.
PostNews: Press Release
PHI announces significant order agreement from Altium for 20 HoloMonitor systems
PHI is excited to announce a significant order agreement from Altium for 20 HoloMonitor systems, which will be shipped in the second half of 2024.
PostNews: Interim Report
Interim Report 1 2024/25
The first quarter of 2024 has so far been a period of steady course and strategic positioning for Phase Holographic Imaging. Most notably, PHI has been very active around the globe in forming important academic and sales partnerships during this summer and preparing for future growth.
PostNews: Press Release
The exercise period for warrants of series TO 4 commences today
Today is the first day for the exercise of Phase Holographic Imaging PHI AB’s warrants of series TO 4 which were issued in connection with the preferential issue of units that the Company carried out during 2022. The period lasts until October 3, 2024.
PostNews: Press Release
The exercise price for warrants of series TO 4 has been set to SEK 4.63 per new share
PHI announces that the exercise price for warrants of series TO 4 has been set at SEK 4.63 per new share.
Company News
Here, you see PHI featured in recent news and find previous CEO commentaries.
BioStock: PHI on the alliance for cell-based biomanufacturing
Kersti Alm, CSO at PHI, visited BioStock’s studio to talk about the recently created alliance for advancing cell-based biomanufacturing and PHI’s pivotal role in the collaboration.
BioStock: PHI part of new regenerative medicine alliance
BioStock contacted Product Manager Lisa Lindström to learn more about PHI’s newly formed technology development alliance for regenerative medicine and what excites her about the future.
BioStock: PHI expands market potential with regenerative medicine opportunity
BioStock contacted CFO Patrik Eschricht to find out more about PHI’s visions regarding regenerative medicine, cell-based therapies and automatization of biomanufacturing.
BioStock: PHIs CEO eyes new business opportunities
BioStock contacted CEO Peter Egelberg to find out more about the rights issue of just over 72 million SEK that is currently underway, and his vision for the future.
